🔗 Share this article

An underground market for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Drug Gaining Traction Via Social Media

Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are urged to message these accounts directly for supplier links, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing market exists on messaging services, where communities with thousands of participants share comparison images, injection guides and claims of rapid British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials suggest it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and pharmacists have cautions that the sale of what is still an unapproved medication in the United Kingdom is worrisome and could result in individuals administering substances of unknown origin.

Some experts said the demand for retatrutide could be linked to the increasing cost of approved slimming products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for human use under the British medical regulations.

Several influencers try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still breach pharmaceutical, marketing, and customer regulations, potentially leading to fines, legal action or prison.

Platform Reaction and Material Elimination

According to the social media company, the platform has taken down violative content and banned associated hashtags and search suggestions. The organization said it was committed to keeping the service secure and investing in strengthening enforcement strategies.

Digital Marketplace Activities

Investigations also found groups with up to 9,000 participants marketing retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of members, filled with photos of weight loss, glowing testimonials and step-by-step guides for preparing or injecting at residence.

Within moments of joining one group, a vendor posted contact information, where most transactions take place. The seller sent an instruction manual and promised shipping within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about weight, health issues or previous experience.

Product Details and Pricing

Inside these groups, posts show dark colored parcels with Royal Mail stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When asked how long a pen should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A representative for Telegram said it actively moderated harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they can’t verify. Even if the science behind retatrutide is sound, these digital products may not include what they advertise,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.

Her team has previously encountered individuals harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company investigational product not yet approved … may subject patients to possibly serious medical dangers”.